---
title: "Cencora: Business Model & Revenue Engine"
description: "Cencora revenue by business segment from its fiscal 2025 Form 10-K, with each part's share, growth and profitability explained."
canonical: https://www.getswoopr.com/stocks/companies/cencora/business-model/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Cencora: Business Model & Revenue Engine



## Direct Answer

Cencora reports revenue across 2 business segments in its fiscal 2025 Form 10-K. US Healthcare Solutions is the largest, with $291 billion of revenue (91% of the total), followed by International Healthcare Solutions at $30.4 billion (9%).

## How Does Cencora Make Money?

US Healthcare Solutions supplies 91% of revenue, so Cencora's results move mostly with that one business; the others matter more for diversification than for the headline number. Between fiscal 2024 and 2025, US Healthcare Solutions grew fastest (+9.7%) and International Healthcare Solutions slowest (+6.1%), so the revenue mix tilts toward US Healthcare Solutions while that gap lasts.

| Segment | FY2025 revenue | FY2024 revenue | Share of revenue | Change |
| --- | --- | --- | --- | --- |
| US Healthcare Solutions | $291 billion | $265 billion | 90.6% | 9.7% |
| International Healthcare Solutions | $30.4 billion | $28.6 billion | 9.5% | 6.1% |

![Bar chart of Cencora revenue by segment for fiscal 2025: US Healthcare Solutions 90.6%, International Healthcare Solutions 9.5%.](https://www.getswoopr.com/images/charts/cencora-business-model-segment-mix.webp)
*Cencora revenue by segment as a share of total revenue, from the table above. The largest is highlighted. Select the chart to open it full size.*

## Which Cencora Segments Earn the Most?

| Segment | FY2025 segment operating income | Segment margin |
| --- | --- | --- |
| US Healthcare Solutions | $3.6 billion | 1.2% |
| International Healthcare Solutions | $648 million | 2.1% |

Segment operating income is the profit measure Cencora reports to its chief operating decision maker for each segment. It usually leaves out corporate costs that are not allocated to a segment, so the segments usually add up to more than consolidated operating income, and margins are comparable within Cencora more safely than against another company.

## What the Segment Figures Do Not Show

The rows above add up to 100% of Cencora's reported revenue for fiscal 2025; the difference is intersegment eliminations, corporate revenue or items the company reports outside its segments. Segment definitions are management's choice and change when a company reorganizes, in which case it restates prior years in the next filing, so a multi-year comparison should use the figures from a single filing. Revenue shows where sales come from, not where profit or cash is earned: a small segment can carry most of the margin.

## Where These Numbers Come From

Every figure on this page is a value Cencora reported in the segment note and revenue disclosures of its Form 10-K filed November 25, 2025 (accession 0001140859-25-000131), read from the SEC's Financial Statement Data Sets. The prior-year column is the comparative figure from that same filing, so it reflects any restatement for a change in segments. Category names are the company's own XBRL labels, lightly reformatted for reading.

Rows that only total other rows (for example a "Products" line beside the individual products) are left out so nothing is counted twice. This page is educational and describes reported history for fiscal 2025; it is not a forecast or a recommendation.

## Frequently Asked Questions

### What are Cencora's business segments?

In its fiscal 2025 Form 10-K, Cencora reports revenue for US Healthcare Solutions and International Healthcare Solutions.

### Which part of Cencora brings in the most revenue?

US Healthcare Solutions, with $291 billion of revenue in fiscal 2025, or 91% of the total.

### Where does Cencora report its segment results?

In the segment note to the financial statements in its Form 10-K, most recently filed November 25, 2025, alongside management's discussion of each segment's results.

## References

- [SEC EDGAR: Cencora, Inc. Form 10-K filed November 25, 2025](https://www.sec.gov/Archives/edgar/data/1140859/000114085925000131/cor-20250930.htm)
- [SEC EDGAR: Cencora, Inc. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1140859&type=10-K)
- [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces)
- [SEC: Financial Statement Data Sets](https://www.sec.gov/data-research/sec-markets-data/financial-statement-data-sets)

## Related Pages

- [Cencora company dossier](https://www.getswoopr.com/stocks/companies/cencora/)
- [Cencora financial metrics](https://www.getswoopr.com/stocks/companies/cencora/metrics/)
- [Cencora financial risk indicators](https://www.getswoopr.com/stocks/companies/cencora/risks/)
- [Cencora peer comparison](https://www.getswoopr.com/stocks/companies/cencora/competitors/)
- [Cencora business model and revenue mix](https://www.getswoopr.com/stocks/companies/cencora/business-model/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)





**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**



Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).